help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 44, No. 6 1023-1031
doi:10.1210/jcem-44-6-1023
Copyright © 1977 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MIZUTANI, S.
Right arrow Articles by MATSUMOTO, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MIZUTANI, S.
Right arrow Articles by MATSUMOTO, K.

Lack of Metabolism of Progesterone, Testosterone and Pregnenolone to 5{alpha}-Products in Monkey and Human estes Compared with Rodent Testes1

S. MIZUTANI*, T. TSUJIMURA, S. AKASHI and K. MATSUMOTO

* Institute for Cancer Research, and Urology Kita-ku, Osaka, Japan
Osaka University Medical School Kita-ku, Osaka, Japan

Testicular homogenates from rhesus monkeys 1.0, 2.0, 2.5, 2.7, 2.8, 3.0, 7, 8, 8.5 and 9 years of age and those from 33- and 100-day-old rats were incubated with 3H-progesterone, 3H-testosterone and 14C-pregnenolone in the presence of co-factors. In addition, homogenates of testes obtained from patients 3, 4, 5, 7, 15 and 83 years of age at the time of orehiectomy were incubated with 3H-progesterone and 14C-pregnenolone. After incubation, radioactive products were separated and identified by column and paper chromatography with derivative formation and recrystallization to constant specific activity.

Testes from monkeys and humans of different ages converted significant amounts (up to 70%) of progesterone and pregnenolone to 17{alpha}-hydroxyprogesterone, androstenedione, testosterone, 20{alpha}-hydroxypregn- 4-en-3-one and/or 16{alpha}-hydroxyprogesterone. Testes of monkeys 1.0–9 years of age converted 1–30% of testosterone to androstenedione. However, no or very small amounts (less than 0.4% of each product) of 5{alpha}-reduced metabolites of {Delta}4–3-ketosteroids were shown to be formed in all monkey and human testes examined. On the other hand, in prepubertal rat testes under the same incubation conditions, conversion of progesterone and testosterone to 5{alpha}-reduced steroids such as 3{alpha}17{alpha}-dihydroxy-5{alpha}-pregnan-20-one, androsterone and 5{alpha}-androstane-3{alpha}, 17β-diol reached 70%. In contrast to rodents, the immature testes of monkeys and humans do not form large amounts of 5{alpha}-reduced C19-steroids. This might reflect a different mechanism controlling testosterone accumulation in the prepubertal testes of monkey and human.

1 The following trivial names and abbreviations are used in this paper: androstane-3{alpha} 17β-diol (A-3{alpha}, 17β-diol), 5{alpha}-androstane-3{alpha}, 17β-diol; androstane-3β, 17β-diol (A-3β, 17β-diol), 5{alpha}-androstane-3β, 17β-diol; 5{alpha}-androstanedione (A-dione), 5{alpha}-androstane-3, 17-dione; dehydroepiandrosterone, 3β-hydroxyandrost-5- en-17-one; dihydrotestosterone (DHT), 17β-hydroxy- 5{alpha}-androstan-3-one; 20{alpha}-dihydroprogesterone, 20{alpha}-hydroxypregn- 4-en-3-one; 5{alpha}-preg-3{alpha}, 17{alpha}-ol-20-one, 3{alpha}, 17{alpha} - dihydroxy - 5{alpha} - pregnan - 20 - one; 5{alpha} - preg - 3ββ17{alpha} - ol - 20 - one, 3β17{alpha} - dihydroxy - 5{alpha} - pregnan - 20 - one; 5{alpha} - preg - 17{alpha} - ol - 3, 20 - one, 17{alpha} - hydroxy - 5{alpha} - pregnane - 3, 20 - dione; epiandrosterone (epian), 3β-hydroxy-5{alpha}-androstan-17-one; 17{alpha}hydroxypregnenolone, 3β, 17{alpha}-dihydroxypregn-5-en- 20-one; 17{alpha}-hydroxyprogesterone, 17{alpha}-hydroxypregn- 4-ene-3, 20-dione; 16{alpha}-hydroxyprogesterone, 16{alpha}-hydroxypregn - 4 - ene - 3, 20 - dione; 3 - OH - 5{alpha} - pregnan-20-one, 3{alpha}-hydroxy-5{alpha}-pregnan-20-one % 3β- hydroxy-5{alpha}-pregnan-20-one; pregnenolone, 3β-hydroxypreg- 5-en-20-one.

Received May 23, 1975.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1977 by The Endocrine Society